YTEN News and Press, Yield10 Bioscience Inc. From 02/05/24

2024-02-05 13:05:53 ET More on Mid-day movers $ stocks. Karyopharm: Approaching The Bottom Ahead Of Earnings And Topline Data (Rating Upgrade) Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky Peraso Inc. (PRSO) Q3 2023 Earnings Ca...

WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with...

2024-01-01 08:00:02 ET Summary In 2023, across two accounts, my portfolios returned +98.4%. In the flagship account, my four-year CAGR (pre-tax), from January 1, 2020 - December 31, 2023, was 46%. This piece discusses what did and didn't work in 2023. What a differen...

2023-12-04 16:40:15 ET Summary The Flagship Account and Smaller Managed Account have performed well year-to-date through November 30, 2023. The blended total return is +71% vs. 4.2% for the Russell 2000. Per Pernas Research, from January 1, 2020 - November 20, 2023, 40.5% of stock...

WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s (...

-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils -On Track for Commercial Launch of Glufosinate Tolerant Camelina as early as 2025 WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Biosci...

2023-11-14 21:57:09 ET Yield10 Bioscience, Inc. (YTEN) Q3 2023 Earnings Conference Call November 14, 2023 16:30 ET Company Participants Lynne Brum - Investor Relations Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research ...

2023-11-14 16:03:55 ET More on Yield10 Bioscience Courage & Conviction Investing On Farmer Bros, Red Robin And Yield10 Bioscience 'Stay Hungry, Stay Foolish' Small Cap Strategies With Courage & Conviction Investing Yield10 Bioscience Q3 2023 Earnings Preview ...

-Establishes "Camelina Seed Genetics to Biofuel" Platform -Advances Herbicide Tolerant Camelina Varieties toward Commercialization -Exercises Option to Finalize Exclusive, Global Commercial License to Advanced Omega-3 Technology -Management will host a conference call today at 4...

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...